Drug intelligence / Profile preview

pyridoxine + prednisolone

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

A combination of pyridoxine (vitamin B6) and prednisolone. Pyridoxine is a vitamin B6 supplement used to prevent or treat vitamin B6 deficiency and peripheral neuropathy, while prednisolone is a corticosteroid with anti-inflammatory and immunosuppressive properties. This combination has been studied for treating infantile spasms and organophosphorus compound-induced delayed neurotoxicity.

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on pyridoxine + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyridoxine + prednisolone.

Explore the full profile